Effect of Caldine® on Renal Function in Balanced Hypertension

Boehringer Ingelheim

Status: Terminated

Conditions: Hypertension

Treatments: Drug: Angiotensin-Converting Enzyme Inhibitors; Drug: alpha blockers; Drug: Diuretics; Drug: antihypertensive drugs; Drug: beta blockers; Drug: Lacidipine

Study type: Observational

Funder types: Industry

Identifiers

NCT02240641

231.334

Details and patient eligibility

About

The study aimed at comparing the evolution of renal function in patients showing a hypertension treated by various therapeutic strategies.

Due to the contract research organisation (CRO) decision in September 2000, the database was locked and not accessible for Boehringer Ingelheim France. Consequently it was decided to stop the study and not proceed to the analysis. Thus, only safety data were processed in the safety database.

Enrollment: 5,417 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with hypertension requiring treatment

Exclusion criteria

• none

Trial design

5,417 participants in 1 patient group

hypertension treatment strategies

Treatment:

Drug: Lacidipine

Drug: antihypertensive drugs

Drug: beta blockers

Drug: alpha blockers

Drug: Angiotensin-Converting Enzyme Inhibitors

Drug: Diuretics